RSI Oversold Bounce Stocks — Performance View · Biological Products, (No Diagnostic Substances)
5 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Performance columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GLUE | Monte Rosa Therapeutics, Inc. | +0.42% | -7.82% | -17.11% | -19.81% | +187.23% | -5.89% | 6.0% | 5.6% | 0.44 | 85K | 14.39 | +1.12% | 38K |
| GRML | Greenland Mines Ltd | -13.46% | -54.96% | -74.29% | — | — | -81.55% | 9.5% | 17.0% | 3.35 | 7K | 4.50 | -7.31% | 22K |
| SCLX | Scilex Holding Co | -5.01% | -18.12% | -29.39% | -36.67% | -71.74% | -59.08% | 3.9% | 4.9% | 0.36 | 5K | 5.31 | -0.56% | 2K |
| PMCB | PharmaCyte Biotech, Inc. | -8.42% | -18.49% | -32.94% | -30.78% | -51.72% | -32.85% | 2.7% | 2.4% | 0.33 | 2K | 0.49 | +1.62% | 800 |
| VIVS | VivoSim Labs, INC. | -6.21% | -24.28% | -79.43% | -86.22% | -88.97% | -85.26% | 4.6% | 9.5% | 0.08 | 102K | 0.28 | -1.01% | 8K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.